Impaired Autophagy Mediates Resistance to Low-Dose Metronomic Cyclophosphamide Chemotherapy

By  

Clinical Cancer Drugs, Vol. 1, Iss. 2, 2014-05 ,pp. : 116-126

Bentham Science Publishers

Access to resources Recommend Favorite

Low- vs high-dose cyclophosphamide in lupus nephritis

By  

Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Low-dose fludarabine plus cyclophosphamide is effective in patients with proliferative lupus nephritis, but is associated with considerable adverse outcomes

By  

Inpharma, Vol. 1, Iss. 1600, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Combination therapy with vinorelbine plus continuous low-dose cyclophosphamide may have activity against childhood sarcomas

By  

Inpharma, Vol. 1, Iss. 1464, 2004-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Combining low-dose cyclophosphamide with GM-CSF–secreting prostate cancer immunotherapy enhances antitumor immune effects

By Antonarakis Emmanuel S   Carducci Michael A  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 2, 2010-02 ,pp. : 311-314

Informa Healthcare

Access to resources Recommend Favorite